Patrick Lebok

2.6k total citations
32 papers, 548 citations indexed

About

Patrick Lebok is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Patrick Lebok has authored 32 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Patrick Lebok's work include Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Cancer Genomics and Diagnostics (6 papers). Patrick Lebok is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Cancer Genomics and Diagnostics (6 papers). Patrick Lebok collaborates with scholars based in Germany, Switzerland and United States. Patrick Lebok's co-authors include Guido Sauter, Ronald Simon, Jakob R. Izbicki, Carsten Bokemeyer, Waldemar Wilczak, Sarah Minner, Andreas H. Marx, Claudia Hube‐Magg, Thorsten Schlomm and Maximillian Bockhorn and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncotarget.

In The Last Decade

Patrick Lebok

31 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Lebok Germany	13	268	191	177	131	74	32	548
Eleonora Lai Italy	14	205 0.8×	315 1.6×	145 0.8×	154 1.2×	93 1.3×	46	572
Muaiad Kittaneh United States	16	294 1.1×	447 2.3×	312 1.8×	149 1.1×	63 0.9×	40	739
Huinian Zhou China	10	390 1.5×	146 0.8×	90 0.5×	207 1.6×	53 0.7×	27	559
Fernanda I. Arnaldez United States	11	202 0.8×	196 1.0×	110 0.6×	84 0.6×	60 0.8×	20	513
Woo Sun Kwon South Korea	16	267 1.0×	401 2.1×	271 1.5×	128 1.0×	43 0.6×	51	677
Yu Heng China	15	212 0.8×	200 1.0×	140 0.8×	147 1.1×	113 1.5×	59	651
Liangcai Wu China	15	277 1.0×	166 0.9×	128 0.7×	200 1.5×	42 0.6×	24	635
Xin Yi China	16	331 1.2×	359 1.9×	288 1.6×	232 1.8×	127 1.7×	66	837
Jason T. Godfrey United States	4	224 0.8×	153 0.8×	106 0.6×	100 0.8×	40 0.5×	5	404
Shalini Makawita United States	11	238 0.9×	242 1.3×	113 0.6×	103 0.8×	39 0.5×	22	545

Countries citing papers authored by Patrick Lebok

Since Specialization

Citations

This map shows the geographic impact of Patrick Lebok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Lebok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Lebok more than expected).

Fields of papers citing papers by Patrick Lebok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Lebok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Lebok. The network helps show where Patrick Lebok may publish in the future.

Co-authorship network of co-authors of Patrick Lebok

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Lebok. A scholar is included among the top collaborators of Patrick Lebok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Lebok. Patrick Lebok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Viehweger, Florian, Franziska Büscheck, Till S. Clauditz, et al.. (2024). Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 Tumors. Biomedicines. 12(5). 957–957. 3 indexed citations

Gorbokon, Natalia, Maximilian Lennartz, Andreas M. Luebke, et al.. (2024). PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entities. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(3). 491–507. 5 indexed citations

Lennartz, Maximilian, Florian Viehweger, David Dum, et al.. (2023). Abstract 5457: Prevalence of “low” HER2 expression is frequent in breast cancer but also in cancers of other origin: A tissue microarray study on 131 tumor types. Cancer Research. 83(7_Supplement). 5457–5457. 1 indexed citations

Lennartz, Maximilian, Niclas C. Blessin, Claudia Hube‐Magg, et al.. (2023). TRPS1 is a highly sensitive marker for breast cancer: A tissue microarray study evaluating more than 19,000 tumors from 152 different tumor entities. American Journal of Clinical Pathology. 160(Supplement_1). S12–S13. 2 indexed citations

Prieske, Katharina, Malik Alawi, Anna Jaeger, et al.. (2021). Transcriptome Analysis in Vulvar Squamous Cell Cancer. Cancers. 13(24). 6372–6372. 4 indexed citations

Lebok, Patrick, Martina Kluth, Christina Möller‐Koop, et al.. (2021). 6q deletion is frequent but unrelated to patient prognosis in breast cancer. Breast Cancer. 29(2). 216–223.

Marx, Andreas H., Doris Höflmayer, Franziska Büscheck, et al.. (2021). Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer. Cancer Biology and Medicine. 18(1). 245–255. 16 indexed citations

Tóth, Réka, Claudia Hube‐Magg, Franziska Büscheck, et al.. (2019). Random forest-based modelling to detect biomarkers for prostate cancer progression. Clinical Epigenetics. 11(1). 148–148. 87 indexed citations

Göbel, Cosima, Martina Kluth, Christian Bernreuther, et al.. (2018). PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer. BMC Cancer. 18(1). 612–612. 12 indexed citations

10.

Lebok, Patrick, Julia Huber, Annette Lebeau, et al.. (2016). Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer. Molecular Medicine Reports. 14(2). 1443–1450. 8 indexed citations

11.

Burdelski, Christoph, Asmus Heumann, Claudia Hube‐Magg, et al.. (2016). p16 upregulation is linked to poor prognosis in ERG negative prostate cancer. Tumor Biology. 37(9). 12655–12663. 8 indexed citations

12.

Kilic, Ergin, Pierre Tennstedt, Patrick Lebok, et al.. (2016). The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 468(4). 483–492. 10 indexed citations

13.

Nienstedt, Julie Cläre, Alexander Gröbe, Patrick Lebok, et al.. (2016). CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer. Clinical Oral Investigations. 21(5). 1503–1508. 4 indexed citations

14.

Milde‐Langosch, Karin, Leticia Oliveira‐Ferrer, Harriet Wikman, et al.. (2015). Relevance of βGal–βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients. Breast Cancer Research and Treatment. 151(3). 515–528. 30 indexed citations

15.

Stahl, Phillip, Patrick Lebok, Asad Kutup, et al.. (2015). Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer. BMC Gastroenterology. 15(1). 7–7. 99 indexed citations

16.

Melling, Nathaniel, Claudia Hube‐Magg, Martina Kluth, et al.. (2015). High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer. PLoS ONE. 10(7). e0134614–e0134614. 14 indexed citations

17.

Burdelski, Christoph, Nathaniel Melling, Christina Koop, et al.. (2015). HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer. Experimental and Molecular Pathology. 98(3). 419–426. 25 indexed citations

18.

Burdelski, Christoph, Maria Christina Tsourlakis, Claudia Hube‐Magg, et al.. (2015). Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers. PLoS ONE. 10(6). e0128525–e0128525. 9 indexed citations

19.

Clauditz, Till S., Patrick Lebok, Sarah Minner, et al.. (2014). Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC). Pathology - Research and Practice. 210(10). 649–655. 14 indexed citations

20.

Clauditz, Till S., Artur Gontarewicz, Patrick Lebok, et al.. (2012). Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: Potentials as therapeutic target. Oral Oncology. 48(10). 991–996. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact